{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "ERK",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O00219",
      "entity_text" : "HAS3",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Our results revealed that TGF-beta1 upregulated the expression of HAS2 and HAS3, which increased the expression of CD44, and subsequently promoted CD44 / EGFR co-localization, and activated the downstream AKT and ERK pathways.",
  "reading_complete" : "2020-08-02T14:59:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:58:14Z",
  "trigger" : "activated",
  "evidence" : [ "HAS3, which increased the expression of CD44, and subsequently promoted CD44/EGFR co-localization, and activated the downstream AKT and ERK" ],
  "pmc_id" : "4494581",
  "score" : 0
}